drugset / Trial / NCT01000467

Pharmacokinetics Study for Probucol

NCT01000467

Phase 4 Completed 30 enrolled Korea Otsuka Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelHealth-services research

Summary

To evaluate the safety and pharmacokinetics of probucol by multiple oral administration in healthy male subjects.

Timeline

Start
2009-02
Primary completion
2009-08
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Probucol Small molecule 250 mg Oral
Comparator Probucol Small molecule 500 mg Oral

Indications

No indication recorded.